KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Merck (MRK) EBIT (2016 - 2025)

Historic EBIT for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $2.9 billion.

  • Merck's EBIT rose 2880000.0% to $2.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.2 billion, marking a year-over-year increase of 55973.03%. This contributed to the annual value of $4.7 billion for FY2024, which is 13331.46% up from last year.
  • According to the latest figures from Q3 2025, Merck's EBIT is $2.9 billion, which was up 2880000.0% from $1.4 billion recorded in Q2 2025.
  • In the past 5 years, Merck's EBIT registered a high of $2.9 billion during Q3 2025, and its lowest value of -$9.4 billion during Q2 2023.
  • For the 5-year period, Merck's EBIT averaged around -$178.6 million, with its median value being $35.0 million (2021).
  • Its EBIT has fluctuated over the past 5 years, first tumbled by 2301666.67% in 2021, then soared by 2880000.0% in 2025.
  • Quarter analysis of 5 years shows Merck's EBIT stood at $35.0 million in 2021, then tumbled by 1151.43% to -$368.0 million in 2022, then plummeted by 1519.02% to -$6.0 billion in 2023, then surged by 105.74% to $342.0 million in 2024, then soared by 745.03% to $2.9 billion in 2025.
  • Its EBIT was $2.9 billion in Q3 2025, compared to $1.4 billion in Q2 2025 and $2.5 billion in Q1 2025.